Scientific Session

Immunodeficiencies

Session: Clinicopathologic Conference: A Woman with Lupus and a New Rash: More Than Skin Deep

Interpretation and Review Part I

Sunday, November 13, 2022

8:15 AM – 8:30 AM Eastern Time

Location: Room 201

Speaker(s)

VW

Victoria Werth, MD

University of Pennsylvania
Wynnewood, PA, United States

Disclosure: Disclosure(s): AbbVie/Abbott: Consultant (Ongoing); Amgen: Consultant (Ongoing), Grant/Research Support (Ongoing); AnaptysBio: Consultant (Ongoing); argenx: Consultant (Ongoing), Grant/Research Support (Ongoing); AstraZeneca: Consultant (Ongoing); Biogen: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol Myers Squibb (BMS): Consultant (Ongoing); Celgene: Consultant (Terminated, December 31, 2021), Grant/Research Support (Terminated, December 31, 2021); Corbus: Grant/Research Support (Ongoing); CSL Behring: Grant/Research Support (Ongoing); Eli Lilly: Consultant (Ongoing); EMD Serono: Consultant (Ongoing); Galderma: Consultant (Ongoing); Genentech: Consultant (Ongoing), Grant/Research Support (Ongoing); Gilead: Consultant (Ongoing); GlaxoSmithKline (GSK): Consultant (Ongoing); Horizon Therapeutics: Consultant (Ongoing), Grant/Research Support (Ongoing); Janssen: Consultant (Ongoing); Merck/MSD: Consultant (Ongoing); Nektar: Consultant (Ongoing); Novartis: Consultant (Ongoing); Octapharma: Consultant (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing); Principia: Consultant (Terminated, December 31, 2021); Regeneron: Consultant (Ongoing), Grant/Research Support (Ongoing); Resolve: Consultant (Terminated, December 31, 2020); Rome Pharmaceuticals: Consultant (Ongoing); Sanofi: Consultant (Ongoing); Syntimmune: Grant/Research Support (Terminated, December 31, 2021); Viela: Consultant (Terminated, December 31, 2021)